Return to content in this issue
Effectiveness of Biologics in Patients With Severe Asthma and Psychiatric Comorbidities
Mascaró-Hereza B1,2, Loli-Ausejo D1,2, Valero A1,2,3¸ Arismendi E3,4,
Bobolea I1,2,3
1Department of Allergy, Hospital Clínic, Barcelona, Spain
2IDIBAPS Clinical and Experimental Respiratory Immunology (IRCE), August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
3CIBER of Respiratory Diseases (CIBERES), Health Institute Carlos III
4Department of Pulmonology, Hospital Clínic, Barcelona, Spain
J Investig Allergol Clin Immunol 2025; Vol. 35(2)
doi: 10.18176/jiaci.1034
Key words: Severe asthma, Biologics, Monoclonal antibodies, Treatment, Comorbidities